Brief: Immutep Granted United States Patent For IMP761, A First-In-Class Agonist Antibody Targeting LAG-3
20/06/2023 14:44
June 20 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP GRANTED UNITED STATES PATENT FOR IMP761, A
FIRST-IN-CLASS AGONIST ANTIBODY TARGETING LAG-3
Source text for Eikon: ID:nGNXbwFmTK
Further company coverage: IMM.AX
(Reuters.Briefs@thomsonreuters.com)